Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
Experimental combo aims to shrink tough lung tumors
Disease control Recruiting nowThis early-stage trial tests the safety and best dose of combining two drugs—vismodegib and atezolizumab—in adults with advanced non-small cell lung cancer that has returned or spread. Vismodegib blocks certain enzymes that help cancer grow, while atezolizumab helps the immune sy…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
New drug combo shows promise for tough lung cancer
Disease control Recruiting nowThis study tests a combination of chemotherapy (temozolomide) and immunotherapy (atezolizumab) for people with small cell lung cancer that has spread or returned after initial treatment. The goal is to see if this combo can shrink tumors and help patients live longer. About 56 ad…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy hopes to boost immune attack on lung cancer
Disease control Recruiting nowThis early-phase trial tests a new drug (PBF-1129) combined with an existing immunotherapy (nivolumab) in 30 adults with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand side effects. Researchers also want to…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 13, 2026 15:58 UTC